A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women

Age and Ageing

Volumn 38, Issue 1, 2009, Pages 86-93

  Gleason, Carey E ^a,b,d   Carlsson, Cynthia M ^a,b   Barnet, Jodi H ^a   Meade, Sarah A ^a   Setchell, Kenneth D R ^c   Atwood, Craig S ^a,b   Johnson, Sterling C ^a,b   Ries, Michele L ^a   Asthana, Sanjay ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d Madison VA GRECC (11G)   (United States)

Author keywords

Cognitive ageing; Daidzein; Elderly; Equol; Genistein; Isoflavone; Phytoestrogen

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; ISOFLAVONE; NOVASOY; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL TENDERNESS; ADULT; AGED; ANOREXIA; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FATIGUE; FEASIBILITY STUDY; FEMALE; FOOT EDEMA; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL PERFORMANCE; MUSCLE WEAKNESS; NAUSEA; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; SPATIAL MEMORY; SWELLING; TREATMENT DURATION; VERBALIZATION; VISUAL MEMORY;

AGED; AGED, 80 AND OVER; COGNITION; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GENISTEIN; GERIATRIC ASSESSMENT; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS;

EID: 58849104984     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afn227     Document Type: Article

References (31)

1. Shumaker SA, Legault C, Thal L et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's HealAh Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651-62.
2. Espeland MA, Rapp SR, Shumacher SA et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2959-68.
3. Sherman S, Miller H, Nerurkar L, Schiff I. Research opportunities for reducing the burden of menopause-related symptoms. Am J Med 2005; 118(Suppl 12B): 166-71.
4. Lee YB, Lee HJ, Sohn HS. Soy isoflavones and cognitive function. J Nutr Biochem 2005; 16: 641-9.
5. Casini ML, Marelli G, Papaleo E et al. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: A randomized, double-blind, crossover, placebo-controlled study. Fertil Steril 2006; 85: 972-8.
6. Celec P, Ostatnikkova D, Caganova M et al. Endocrine and cognitive effects of short-time soybean consumption in women. Gynecol Obstet Invest 2005; 59: 62-6.
7. Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav 2003; 75: 721-9.
8. File SE, Hartley DE, Elsabagh S, Duffy R, Wiseman H. Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause 2005; 12: 193-201.
9. File SE, Jarrett N, Fluck E, Duffy R, Casey K, Wiseman H. Eating soya improves human memory. Psychopharmacology (Berl) 2001; 157: 430-6.
10. Kritz-Silverstein D, Von Muhlen D, Barrett-Connor E, Bressel MA. Isoflavones and cognitive function in older women: The SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause 2003; 10: 196-202.
11. Marinac JS, Buchinger CL, Godfrey LA et al. Herbal products and dietary supplements: A survey of use, attitudes, and knowledge among older adults. J Am Osteopath Assoc 2007; 107: 13-20; quiz 21-3.
12. Kreijkamp-Kaspers S, Kok L, Grobbee DE et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: A randomized controlled trial. JAMA 2004; 292: 65-74.
13. Setchell KDR, Brown NM, Desai P et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001; 131: 1362S-75S.
14. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 2002; 132: 3577-84.
15. Frankenfeld CL, Atkinson C, Thomas WK et al. Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med (Maywood) 2004; 229: 902-13.
16. Setchell KD, Brown NM, Zimmer-Nechemias L et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002; 76: 447-53.
17. World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. J Int Bioethique 2004; 15: 124-9.
18. Frankenfeld CL, Patterson RD, Kalhorn TF et al. Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults. J Am Diet Assoc 2002; 102: 1407-13.
19. Setchell KD, Faughnan MS, Avades T et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 2003; 77: 411-9.
20. Hettmansperger TP, McKean JW. Robust nonparametric statistical methods. Kendall's Library of Statistics, Vol. 5. London/New York: Arnold/Wiley, 1998; xi, 467.
21. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983; 40: 812.
22. Burke WJ, Roccaforte WH, Wengel SP. The short form of the Geriatric Depression Scale: A comparison with the 30-item form. J Geriatr Psychiatry Neurol 1991; 4: 173-8.
23. Bloedon LT, Jeffcoat AR, Lopaczynski W et al. Safety and pharmacokinetics of purified soy isoflavones: Single-dose administration to postmenopausal women. Am J Clin Nutr 2002; 76: 1126-37.
24. Busby M, Jeffcoat AR, Bloedon LT et al. Clinical characteristics and pharmacokinetics of purified soy isoflavones: Single-dose administration to healthy men. Am J Clin Nutr 2002; 75: 126-36.
25. Setchell KD, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006; 136: 2188-93.
26. Makin HLJ. Analytical standards and quality assurance for high-quality analysis of isoflavones in soy foods, serum, and urine. J Nutr 2004; 134: 1240S.
27. Wu J, Oka J, Ezaki J et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: A double-blind, randomized, controlled trial. Menopause 2007.
28. Clerici C, Setchell KDR, Battezzati PM et al. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr 2007; 137: 2270-2278.
29. Ho SC, Chan As, Ho YP et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: A double-blind, randomized, controlled trial. Menopause 2007; 14(Pt 1): 489-99.
30. Fournier LR, Ryan Borchers TA, Robinson LM et al. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J Nutr Health Aging 2007; 11: 155-64.
31. Pike AC, Brzozowoski AM, Hubbard RE et al. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18: 4608-18.